Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease

[1]  M. Suematsu,et al.  Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease , 1988, Digestive Diseases and Sciences.

[2]  R. Farmer,et al.  Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease , 1981, Digestive Diseases and Sciences.

[3]  T. Strom,et al.  Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. , 1991, Journal of immunology.

[4]  A. Cerami,et al.  Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis. , 1991, Gastroenterology.

[5]  P. Simon,et al.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease. , 1990, Gut.

[6]  T. Strom,et al.  Transcriptional modulation of human IL-6 gene expression by verapamil. , 1990, Journal of immunology.

[7]  M. Jourdan,et al.  Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.

[8]  D. Jewell,et al.  Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease , 1990, Clinical and experimental immunology.

[9]  堀井 康弘.  Involvement of IL-6 in mesangial proliferative glomerulonephritis , 1990 .

[10]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[11]  T. Strom,et al.  Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. , 1990, Transplantation.

[12]  A. Muraguchi,et al.  Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.

[13]  M. Jourdan,et al.  Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. , 1989, The Journal of clinical investigation.

[14]  T. Hirano,et al.  Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Steinman,et al.  IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. , 1989, Journal of immunology.

[16]  T. Luger,et al.  IFN-beta 2/IL-6 augments the activity of human natural killer cells. , 1989, Journal of immunology.

[17]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[18]  Y. Mahida,et al.  Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. , 1989, Gut.

[19]  C. Dinarello.  Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[20]  T. Hirano,et al.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.

[21]  J. Ghrayeb,et al.  Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts , 1988, The Journal of experimental medicine.

[22]  A. Tsou,et al.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Strom,et al.  Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. , 1987, Journal of immunology.

[24]  P. Lipsky,et al.  Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. , 1987, Journal of immunology.

[25]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Scheurich,et al.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. , 1987, Journal of immunology.

[27]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[28]  E. Unanue,et al.  Conditions required for expression of membrane IL 1 on B cells. , 1985, Journal of immunology.

[29]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[30]  M. Donowitz,et al.  Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. , 1985, Gastroenterology.

[31]  S. Krane,et al.  Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. , 1985, Collagen and related research.

[32]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[33]  W. Stenson,et al.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. , 1984, Gastroenterology.

[34]  J. Kirsner,et al.  Recent Developments in Nonspecific Inflammatory Bowel Disease , 1982 .

[35]  P. Whorwell,et al.  Monocyte function in Crohn's disease and ulcerative colitis. , 1981, Digestion.

[36]  F. Bosman,et al.  Evidence for predominant involvement of the B-cell system in the inflammatory process in Crohn's disease. , 1979, Scandinavian journal of gastroenterology.

[37]  C. Byus,et al.  Ribonucleic acid isolated by cesium chloride centrifugation. , 1974, Biochemistry.

[38]  F. T. de Dombal,et al.  Short-term course and prognosis of Crohn's disease , 1974, Gut.

[39]  P. Perlmann,et al.  AUTOANTIBODIES IN HUMAN ULCERATIVE COLITIS , 1959, The Journal of experimental medicine.